When evaluating the protein expression with immunohistochemistry, results showed that SLC25A43 expression varied between negative to high among HER2-positive breast cancers and was not associated with ER status, lymph node metastasis or age at diagnosis. Here, SLC25A43 is linked to breast cancer.